Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Trial details
- Registry ID
- NCT05303064
- Drugs studied
- OLZ/SAM, Olanzapine
TrialRedline tracks 10 clinical trials sponsored by Alkermes, Inc.: 6 Phase 3, 1 Phase 2 / 3, 3 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaNCT06767683 | ALKS 2680, 10mg, ALKS 2680, 14mg, ALKS 2680, 18mg, ALKS 2680, 4mg and 2 more | Recruiting | 2030-06Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaNCT06843590 | ALKS 2680 | Active not recruiting | 2026-11Estimated |
| A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2NCT06555783 | ALKS 2680 | Completed | 2025-11-11Actual |
| A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)NCT06358950 | ALKS 2680 | Completed | 2025-06-19Actual |
Names as written in the registry records.
Before: Sep 2026. After: Dec 2027.
NCT06767683 · Alkermes, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of Treatment-Emergent Adverse Events Time frame: Up to 100 Weeks. After: Measure: Incidence of Treatment-Emergent Adverse Events Time frame: Up to 248 Weeks.
Before: 256 participants (planned). After: 786 participants (planned).
Before: Jun 2028. After: Jun 2030.
NCT06843590 · Alkermes, Inc.
Before: Recruiting. After: Active not recruiting.
NCT06843590 · Alkermes, Inc.
Before: 96 participants (planned). After: 126 participants (planned).
Before: Jun 2026. After: Nov 2026.
Before: Not yet recruiting. After: Recruiting.
NCT07455383 · Alkermes, Inc.
Before: Not yet recruiting. After: Recruiting.
NCT07502443 · Alkermes, Inc.
Before: Not yet recruiting. After: Recruiting.
NCT06555783 · Alkermes, Inc.
Before: Estimated. After: Actual.
Before: 80 participants (planned). After: 93 participants (actual).
Before: Estimated. After: Actual.
Before: Nov 2025. After: 11 Nov 2025.
Before: Active not recruiting. After: Completed.